PATH malaria
pathmalaria.bsky.social
PATH malaria
@pathmalaria.bsky.social
With #malaria #vaccines on the market, we're developing next-gen vaccines and monoclonal antibodies to bring us closer to #malariaeradication. Read about the @who.int-commissioned impact value assessment of malaria vaccines and prophylactic #mAbs in the pipeline: shorturl.at/CgG0J
Value profile for Malaria vaccines and monoclonal antibodies
Malaria remains a leading cause of morbidity and mortality and is responsible for over 0.5 million annual deaths globally. During the first two decade…
shorturl.at
November 19, 2025 at 1:55 PM
On #WorldMalariaDay, we reflect on the progress achieved and reaffirm our commitment to a malaria-free future. Sustained investment in prevention, control, and eradication efforts is crucial. We are at a pivotal moment 🌍 Help support our lifesaving efforts give.path.org/campaign/665...
Donate to PATH's emergency appeal
Because of the US cuts to foreign aid, PATH faces a critical funding gap that threatens 30% of our high-stakes health programs. Help us continue this lifesaving work—from vaccinating people against d...
give.path.org
April 25, 2025 at 5:24 PM
Reposted by PATH malaria
Combining #malaria interventions like chemoprevention, bed nets and vaccines can be highly effective, and as researchers argue in a report published in the Malaria Journal, implementation context is paramount. Read more: bit.ly/4cpc3AP
April 10, 2025 at 1:59 PM
Reposted by PATH malaria
Accelerating progress for maternal & newborn health could save over 7 million lives by the end of this decade.

📢 This #WorldHealthDay, learn how advocates & decision-makers can drive action to help moms and children survive + thrive: bit.ly/4couuWm

#HopefulFutures @who.int
April 7, 2025 at 4:36 PM
This #WorldHealthDay, we highlight our GiveWell Perennial Malaria Chemoprevention project that has helped more than 43,000 children in the DRC start their #healthybeginning by delivering antimalarial drugs to infants and children in their first 2 years of life.
April 7, 2025 at 4:39 PM
Reposted by PATH malaria
The fight against malaria needs the energy and innovation of young leaders. With the right support and resources, the youth can drive action and mobilize funding to end malaria for good. It's our future, let's protect it. #PowerUpHealth
@pathmalaria.bsky.social @malariaconsortium.bsky.social
March 18, 2025 at 4:34 AM
Reposted by PATH malaria
Everyone has a right to lifesaving vaccines, no matter where they live. At PATH, we’re proud to work with @gavi.org to give hundreds of millions of children a fair chance at a healthy life.

But millions more still miss out. It’s time to fully fund Gavi ➡️ bit.ly/3KQTvMQ

#VaccinesWork #ForOurFuture
February 11, 2025 at 1:29 PM
Reposted by PATH malaria
No child should miss out on protection from a vaccine-preventable disease.

Learn more about Burkina Faso’s efforts to end typhoid: www.path.org/our-impact/a...

#GlobalHealth #VaccinesWork
Preventing typhoid with vaccines in Burkina Faso
Burkina Faso introduced typhoid conjugate vaccines (TCVs), becoming the first in Francophone Africa to include TCVs in the routine childhood immunization schedule.
www.path.org
February 4, 2025 at 1:32 PM
Reposted by PATH malaria
🎉It's #WorldNTDDay! 1.5 billion people remain affected by Neglected Tropical Diseases. We are proud to join the collective movement to #UniteActEliminate and #EndNTDs!
January 30, 2025 at 12:29 PM
Reposted by PATH malaria
🌟 The first point-of-care diagnostic test for G6PD deficiency has achieved @who.int prequalification 🌟

Developed by SD Biosensor & PATH, the STANDARD G6PD Test is a critically needed tool. Congrats to the many partners who contributed to this milestone in the fight to #EndMalaria!

bit.ly/3PKB0fj
January 16, 2025 at 10:49 PM
Reposted by PATH malaria
As we face multiple health crises — including #mpox, #cholera, and #AMR — a strong & effective @who.int is more critical than ever. We urge the Trump Administration to reconsider its position on US withdrawal from WHO.

Read our full statement: bit.ly/3EhfXys
PATH statement on US withdrawal from WHO
bit.ly
January 21, 2025 at 7:57 PM
Reposted by PATH malaria
#VaccinesWork

@gavi.org reports on Cameroon’s #malaria vaccine rollout, one year into the campaign ⏬
January 24, 2025 at 10:03 PM
Reposted by PATH malaria
@pathmalaria.bsky.social
is hiring! Are you an early-career professional interested in building your skills in data analysis through a mentorship program while providing support to National Malaria Programs in either DRC, CAR, or Nigeria? Check us out!

path.wd1.myworkdayjobs.com/en-US/Extern...
Four (4) - Data Analytics Fellows - Malaria - Central Africa Republic - Democratic Republic of Congo - Nigeria
PATH current employees - please log in and apply Here PATH is a global nonprofit dedicated to achieving health equity. With more than 40 years of experience forging multisector partnerships and with e...
path.wd1.myworkdayjobs.com
January 22, 2025 at 7:12 PM
As another year ends, @PATHMalaria reflects on all we've accomplished with our partners. We remain committed to the audacious goal to #EndMalaria for all, even amidst challenges like #AMDR and climate change. In this 🧵, we share photos illustrating key moments in 2024. (1/11)
December 18, 2024 at 8:08 PM
@who.int has released their #WorldMalariaReport! Although major progress has been made, we must continue to commit ourselves to an equitable and aligned fight against #malaria. bit.ly/3VzeTvE
December 11, 2024 at 5:37 PM
New study from Namibia shows that malaria rapid diagnostic tests (RDTs) can stay positive for weeks after treatment. Standard RDTs had a median positivity of 42 days, while new ultra-sensitive RDTs remined positive for 67 days. Implications for surveillance & elimination. 🦟🔬 tinyurl.com/ymfrbwjz
ScienceDirect.com
December 9, 2024 at 6:42 PM
Exciting news: @who.int has prequalified tafenoquine, a single-dose treatment for relapsing P. vivax malaria, and added it to their latest #malaria guidelines. Check it out 👇https://www.mmv.org/newsroom/news-resources-search/first-single-dose-medicine-p-vivax-malaria-prequalified-who-and
First single-dose medicine for P. vivax malaria prequalified by WHO and included in WHO Guidelines | Medicines for Malaria Venture
The World Health Organization has awarded prequalification to tafenoquine, the first single-dose medicine for the prevention of relapse of Plasmodium vivax malaria.
www.mmv.org
December 6, 2024 at 9:38 PM
Fresh from ASTMH, PATH malaria team are excited to get started on Bluesky! Who's good to follow? Anyone read any good papers recently?
November 20, 2024 at 5:51 PM